BrightSpring Health Services (BTSG) EBITDA (2023 - 2026)

BrightSpring Health Services (BTSG) has 4 years of EBITDA data on file, last reported at $121.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 139.36% year-over-year to $121.4 million; the trailing twelve-month figure through Mar 2026 stood at $99.7 million (down 42.72% YoY), and the FY2025 full-year result was $29.0 million, down 73.17% from the prior year.
• EBITDA for Q1 2026 stood at $121.4 million, up from -$158.2 million in the prior quarter.
• Across five years, EBITDA topped out at $121.4 million in Q1 2026 and bottomed at -$158.2 million in Q4 2025.
• The 4-year median for EBITDA is $48.6 million (2025), against an average of $16.4 million.
• Peak annual rise in EBITDA reached 430.87% in 2025, while the deepest fall reached 384.79% in 2025.
• A 4-year view of EBITDA shows it stood at -$123.8 million in 2023, then surged by 144.86% to $55.5 million in 2024, then slumped by 384.79% to -$158.2 million in 2025, then surged by 176.78% to $121.4 million in 2026.
• The last three EBITDA figures came in at $121.4 million (Q1 2026), -$158.2 million (Q4 2025), and $87.8 million (Q3 2025), per Business Quant data.

Peer Comparison